Skip to main content
Premium Trial:

Request an Annual Quote

Nicholas Naclerio, Tom Willis, Mostofa Ronaghi, Kim Blickenstaff, Jacqueline Barton

Premium

Nicholas Naclerio has been appointed president of ParAllele BioScience, the company said last week. Naclerio comes to the South San Francisco genotyping company from a stint as an independent consultant for life sciences and venture capital companies. Before that, he was chief business officer of protein chip company Zyomyx between November 2001 and early 2002. Previously, Naclerio was an executive at Motorola, where he founded the company’s life sciences business unit and led the launch of its CodeLink microarray platform between the late 1990s and 2001. He was an assistant director at the US government’s Defense Advanced Research Projects Agency before joining Motorola. Naclerio has also served on the boards of Orchid BioScience, Genometrix, the SNP Consortium, and Clinical Microsensors, which Motorola acquired in 2000. Tom Willis, Par-Allele’s current president, has been appointed chief scientific officer. Mostofa Ronaghi, a co-founder of the company, will leave the board of directors, and will join the company’s scientific advisory board.



Kim Blickenstaff joins the board of directors of GeneOhm Sciences, a San Diego-based company commercializing a biochip-based diagnostic technology invented by Jacqueline Barton of the California Institute of Technology. Blickenstaff is co-founder, president, and chief executive officer of Biosite.

 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.